Kendal Chidwick is a pharmacoepidemiologist and PhD candidate at the National Drug and Alcohol Research Centre, UNSW Sydney.  She is currently working on projects to synthesize the evidence on innovate approaches to service provision for the treatment of opioid use disorder, compare treatments for the acute management of opioid withdrawal, describe trends in the sales of opioid agonist treatment medicines, and the impact of the introduction of long-acting injectable buprenorphine.  Prior to this Kendal led the MedicineInsight Real World Research team at NPS MedicineWise and worked at the Clinical Practice Research Datalink (CPRD) at the MHRA. Kendal is a member of the Drug Utilisation Sub Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC).